Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
First quarter total revenue of approximately EUR 5.9 million (USD 7.8 million), up 23% year-over-year Ten lithotripsy devices sold in first quarter 2013 Received FDA acceptance for PMA...
-
EATONTOWN, N.J., April 11, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, today announced that the Company is...
-
ALPHARETTA, Ga., April 11, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Method and Devices for Cleaning...
-
Sanoma Corporation, Press Release, 11 April 2013 at 15:30 CET+1 Unique and high quality range of new, outlet and vintage children’s clothing SanomaVentures is investing in the online children’s...
-
Den första minuten under jobbintervjun är avgörande för vilket intryck man gör. Därför är det oerhört viktigt vad vi gör och säger under jobbintervjun. Det visar en ny studie från University of...
-
Projekts Sapulces norise 2013. gada 25. aprīlī plkst.14:00 Akciju sabiedrības “Tosmares kuģubūvētava” reģistrācijas numurs 210302283, Ģenerāļa Baloža iela 42/44, Liepāja,...
-
Project of the Annual shareholders meeting to be held on April 25, 2013 at 14:00 JSC Tosmare Shipyard (A/s “Tosmares kuģubūvētava”) Registration No.210302283, 42/44 Generala Baloza...
-
LOS ANGELES, CA--(Marketwired - Apr 11, 2013) - MyMedicalRecords, Inc. ("MMR"), a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF), today announced the filing of a complaint for patent...
-
TEL AVIV, Israel and WHITE PLAINS, N.Y., April 11, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a development-stage company with a novel therapeutic technology...
-
RESEARCH TRIANGLE PARK, N.C., April 11, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need,...